Greater Poland Cancer Centre, Garbary 15 St, 61-866, Poznan, Poland.
Instituto Português de Oncologia; do Porto FG, EPE (IPO-Porto), Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
Radiat Oncol. 2020 Aug 27;15(1):208. doi: 10.1186/s13014-020-01648-7.
To perform a clinical audit to assess adherence to standard clinical practice for the diagnosis, treatment, and follow-up of patients undergoing radiotherapy for rectal cancer treatment in four European countries.
Multi-institutional, retrospective cohort study of 221 patients treated for rectal cancer in 2015 at six European cancer centres. Clinical indicators applicable to general radiotherapy processes were evaluated. All data were obtained from electronic medical records.
The audits were performed in the year 2017. We found substantial inter-centre variability in adherence to standard clinical practices: 1) presentation of cases at departmental clinical sessions (range, 0-100%) or multidisciplinary tumour board (50-95%); 2) pretreatment MRI (61.5-100%) and thoracoabdominal CT (15.0-100%). Large inter-centre differences were observed in the mean interval between biopsy and first visit to the radiotherapy department (range, 21.6-58.6 days) and between the first visit and start of treatment (15.1-38.8 days). Treatment interruptions ≥ 1 day occurred in 43.9% (2.5-90%) of cases overall. Treatment compensation was performed in 2.1% of cases. Treatment was completed in the prescribed time in 55.7% of cases.
This multi-institutional clinical audit revealed that most centres adhered to standard clinical practices for most of the radiotherapy processes-related variables assessed. However, the audit revealed marked inter-centre variability for certain quality indicators, particularly inconsistent record keeping. Multiple targets for improvement and/or harmonisation were identified, confirming the value of routine clinical audits to detect potential deviations from standard clinical practice.
进行临床审核,以评估在四个欧洲国家对接受直肠癌放疗治疗的患者的诊断、治疗和随访是否符合标准临床实践。
这是一项多机构、回顾性队列研究,纳入了 2015 年在欧洲 6 个癌症中心接受直肠癌治疗的 221 例患者。评估了适用于一般放疗过程的临床指标。所有数据均来自电子病历。
审核于 2017 年进行。我们发现各中心之间在遵守标准临床实践方面存在很大差异:1)在科室临床会议(范围为 0-100%)或多学科肿瘤委员会(50-95%)上呈现病例;2)治疗前 MRI(61.5-100%)和胸腹 CT(15.0-100%)。在活检与放疗科首次就诊(范围为 21.6-58.6 天)以及首次就诊与开始治疗(15.1-38.8 天)之间的平均间隔时间,以及治疗中断(≥1 天)的发生率(总体为 43.9%,2.5-90%)方面,各中心之间存在较大差异。在 2.1%的病例中进行了治疗补偿。55.7%的病例按时完成了治疗。
这项多机构临床审核显示,大多数中心在评估的大多数放疗过程相关变量方面都符合标准临床实践。然而,审核显示某些质量指标存在明显的中心间差异,特别是记录保存不一致。确定了多个需要改进和/或协调的目标,证实了常规临床审核对于发现潜在的偏离标准临床实践具有价值。